Cargando…
From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) ranks the most common primary liver malignancy and the third leading cause of tumor-related mortality worldwide. Unfortunately, despite advances in HCC treatment, less than 40% of HCC patients are eligible for potentially curative therapies. Recently, cancer immunother...
Autores principales: | Fu, Yaojie, Liu, Shanshan, Zeng, Shan, Shen, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734524/ https://www.ncbi.nlm.nih.gov/pubmed/31500650 http://dx.doi.org/10.1186/s13046-019-1396-4 |
Ejemplares similares
-
The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: Bertino, Gaetano, et al.
Publicado: (2015) -
Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses
por: Gao, Xingxing, et al.
Publicado: (2021) -
Retracted: The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: BioMed Research International,
Publicado: (2016) -
Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma
por: Koh, Benjamin, et al.
Publicado: (2023) -
Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
por: Pombo Antunes, Ana Rita, et al.
Publicado: (2020)